https://www.biospace.com/oramed-pharmaceuticals-appoints-chief-legal-officer
Oramed Pharmaceuticals Appoints Chief Legal Officer - BioSpace
Dec 8, 2021 - Oramed Pharmaceuticals Inc. today announced the appointment of Netanel Derovan to serve as Chief Legal Officer (General Counsel) and Company Secretary,...
chief legal officeroramedpharmaceuticalsappoints
https://www.fiercebiotech.com/biotech/oramed-hits-midstage-target-oral-insulin-trial
Oramed hits midstage target in oral insulin trial | Fierce Biotech
May 18, 2016 - Hoping to get in on the potentially $15 billion oral insulin market, Israeli biotech Oramed ($ORMP) has released positive top-line results for its experimental...
oral insulinoramedhitstargettrial
https://www.lawinsider.com/contracts/gK0o8QUFxk1
INDEMNIFICATION AGREEMENT by Oramed Pharmaceuticals Inc. | Law Insider
INDEMNIFICATION AGREEMENT filed by Oramed Pharmaceuticals Inc. on August 14th, 2024
indemnification agreementoramedpharmaceuticalsinclaw
https://www.prnewswire.com/il/news-releases/oramed-letter-to-shareholders-301708155.html
Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development...
oramedlettershareholders
https://www.macrotrends.net/stocks/charts/ORMP/oramed-pharmaceuticals/quick-ratio
Oramed Pharmaceuticals Quick Ratio 2012-2025 | ORMP | MacroTrends
Historical quick ratio values for Oramed Pharmaceuticals (ORMP) over the last 10 years.
quick ratiooramedpharmaceuticals20122025
https://www.macrotrends.net/stocks/charts/ORMP/oramed-pharmaceuticals/roi
Oramed Pharmaceuticals Return on Investment 2012-2025 | ORMP | MacroTrends
Current and historical return on investment (ROI) values for Oramed Pharmaceuticals (ORMP) over the last 10 years.
return on investmentoramedpharmaceuticals20122025
https://www.biospace.com/endocrinology-diabetes-and-metabolism-journal-publishes-scientific-paper-authored-by-oramed-scientists
Endocrinology, Diabetes and Metabolism Journal Publishes Scientific Paper Authored by Oramed...
Oct 17, 2017 - Oramed announced today the publication of a new paper co-authored by Oramed's CSO, Dr. Miriam Kidron, Dr. Roy Eldor, Dr. Ehud Arbit and Dr. Yael...
diabetes and metabolismscientific paperendocrinologyjournal
https://www.fiercebiotech.com/keyword/oramed
Oramed | Fierce Biotech
oramedfiercebiotech
https://www.finanznachrichten.de/nachrichten-2026-03/68042496-lifeward-ltd-lifeward-successfully-closes-on-strategic-partnership-with-oramed-399.htm
Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in...
strategic partnershipltdsuccessfullyclosesoramed
https://www.home.saxo/markets/stocks/ormp-xnas
Oramed Pharmaceuticals Inc. stock | Saxo
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform...
oramedpharmaceuticalsincstocksaxo
https://www.biospace.com/oramed-pharmaceuticals-inc-obtains-dual-listing-on-frankfurt-stock-exchange
Oramed Pharmaceuticals Inc. Obtains Dual Listing On Frankfurt Stock Exchange - BioSpace
frankfurt stock exchangedual listingoramedpharmaceuticalsinc
https://www.prnewswire.co.uk/news-releases/frost--sullivan-publishes-quarterly-update-on-oramed-pharmaceuticals-inc-nasdaqtase-ormp---oramed-has-a-682151662.html
Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) -...
/PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investors' awareness to TASE listed technology and life-science companies...
frost sullivanquarterly update
https://www.macrotrends.net/stocks/charts/ORMP/oramed-pharmaceuticals/net-worth
Oramed Pharmaceuticals Net Worth 2012-2025 | ORMP | MacroTrends
Interactive chart of historical net worth (market cap) for Oramed Pharmaceuticals (ORMP) over the last 10 years. How much a company is worth is typically...
net worthoramedpharmaceuticals20122025